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Background
The prevalence of gestational diabetes mellitus (GDM) is increasing worldwide. Cur-
rently, it affects about 2.6 % of pregnant women in southern Sweden (Hunt and Schuller 
2007; Ignell et al. 2014). GDM is an important risk factor for type-2 diabetes and car-
diovascular disease (Bellamy et  al. 2009; Harreiter et  al. 2014). A cumulative diabe-
tes incidence of 30–50 % within 5–10 years after GDM has been described (Kim et al. 
2002; Ekelund et  al. 2010). GDM and type-2 diabetes have many risk factors in com-
mon (Dornhorst and Rossi 1998), and both are characterized by insulin resistance and 
an inability of the beta cells to compensate by a sufficient increase in insulin secretion 
Abstract 
Aims: To identify predictors of diabetes development up to 5 years after gestational 
diabetes mellitus (GDM) and to develop a prediction model for individual use.
Methods: Five years after GDM, a 75-g oral glucose tolerance test (OGTT) was per-
formed in 362 women, excluding women already diagnosed with diabetes at 1- to 
2-year follow-up or later (n = 45). All but 21 women had results from follow-up at 
1–2 years, while 84 women were lost from that point. Predictive variables were identi-
fied by logistic regression analysis.
Results: Five years after GDM, 28/362 women (8 %) were diagnosed with diabetes 
whereas 187/362 (52 %) had normal glucose tolerance (NGT). Of the latter, 139/187 
(74 %) also had NGT at 1- to 2-year follow-up. In simple regression analysis, using NGT 
at 1–2 years and at 5 years as the reference, diabetes at 1- to 2-year follow-up or later 
was clearly associated with easily assessable clinical variables, such as BMI at 1- to 
2-year follow-up, 2-h OGTT glucose concentration during pregnancy, and non-Euro-
pean origin (P < 0.0001). A prediction model based on these variables resulting in 86 % 
correct classifications, with an area under the receiver-operating characteristic curve 
of 0.91 (95 % CI 0.86–0.95), was applied in a function-sheet line diagram illustrating the 
individual effect of weight on diabetes risk.
Conclusions: The results highlight the importance of BMI as a potentially modifiable 
risk factor for diabetes after GDM. Our proposed prediction model performed well, and 
should encourage validation in other populations in future studies.
Keywords: Diabetes mellitus, Follow-up, Gestational diabetes mellitus, Glucose 
tolerance, Prediction
Open Access
© 2016 Ignell et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made.
RESEARCH




2 Department of Obstetrics 
and Gynecology, 
Helsingborg Hospital, SE-251 
87 Helsingborg, Sweden
Full list of author information 
is available at the end of the 
article
Page 2 of 11Ignell et al. SpringerPlus  (2016) 5:318 
(Buchanan et  al. 2007; Retnakaran et  al. 2008). However, the incidence of GDM and 
type-2 diabetes following GDM is dependent of the screening activity and the diagnos-
tic criteria used to define GDM. In southern Sweden, universal screening with a 75-g 
oral glucose tolerance test (OGTT) has been used since 1995. Using the World Health 
Organization (WHO) criteria from 1999 to define GDM, we have previously reported a 
diabetes incidence of 6 % 1–2 years after delivery (Anderberg et al. 2011; World Health 
Organization 1999). Here we report the results of 5-year follow-up of these women.
As intervention studies have shown that type-2 diabetes can be prevented by mod-
ification of lifestyle (Knowler et  al. 2002; Lindstrom et  al. 2003), even in women with 
a history of GDM (Ratner et  al. 2008; Aroda et  al. 2015), a major challenge in public 
healthcare is to identify individuals who have the highest risk (Noble et al. 2011). The 
aim of the present study was to identify risk factors associated with diabetes develop-
ment up to 5 years after pregnancy and to explore the possibility of establishing a model 
for diabetes prediction that could be used in clinical practice on an individual basis when 
counseling women after GDM.
Methods
Study population
The present study was part of the Mamma Study, which was conducted in four of the five 
delivery departments in the county of Skåne in southern Sweden. The design of the study 
has been described in detail elsewhere (Anderberg et al. 2011; Ignell et al. 2013). Briefly, 
during the years 2003–2005, all pregnant women, representing different glucose cate-
gories according to an OGTT, were invited to take part in a 5-year follow-up program 
postpartum. A 75-g OGTT was offered to all women in the 28th week of gestation, and 
also in gestational week 12 if they had had a history of GDM in previous pregnancies or 
a first-degree relative with diabetes. The diagnostic criteria for GDM used in the present 
study were a modification of those recommended by the WHO in 1999, defining GDM 
as the joint category of diabetes and impaired glucose tolerance (IGT) based on the 2-h 
capillary plasma glucose concentration (World Health Organization 1999). A 2-h capil-
lary plasma glucose concentration below the limit for IGT was considered to be normal 
glucose tolerance (NGT) during pregnancy (GNGT) (World Health Organization 1999).
The first follow-up appointment took place 1–2 years after delivery (Anderberg et al. 
2011; Ignell et  al. 2013). A 75-g OGTT was performed after overnight fasting in 470 
women with previous GDM, and in 166 women with previous GNGT. Fasting and 2-h 
venous blood samples were drawn in duplicate for determination of plasma glucose con-
centration, and the mean value was calculated. Diagnostic criteria were those proposed 
by the WHO (World Health Organization 1999). Weight and height were measured and 
body mass index (BMI) calculated (kg/m2). Information on first-grade family history of 
diabetes, earlier pregnancies, smoking/snuff habits, and ethnic affiliation was obtained. 
Based on the stated country of origin of at least three grandparents, women were 
grouped according to whether they were of European or non-European origin. Using 
this definition, 14 women with previous GDM were unclassifiable. In all, 32 women were 
diagnosed with diabetes 1–2 years after delivery (all GDM) and were referred to primary 
care for clinical surveillance. During the two subsequent years, 13 other women with 
previous GDM (3 NGT and 10 IGT at 1–2 years) were given a diabetes diagnosis.
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The second and final follow-up took place 5 years after pregnancy and followed the 
same procedure as the 1- to 2-year follow-up, except for capillary blood sampling dur-
ing the OGTT for the determination of plasma glucose concentrations. A flow chart of 
the study population is shown in Fig. 1. In addition to the 45 women already diagnosed 
with diabetes after GDM, 84 women with GDM and 29 women with GNGT were lost to 
follow-up at this point. However, 25 women who did not attend the 1- to 2-year appoint-
ment attended the 5-year appointment (4 GNGT, 21 GDM).
Informed consent was obtained from all individual participants included in the study, 
and the study protocol was approved by the Ethics Committee of Lund University, Swe-
den (LU 259-00).
Metabolic measurements
The HemoCue Glucose 201+ system (HemoCue AB, Ängelholm, Sweden) was used for 
immediate measurement of plasma glucose concentrations (mmol/L). The mean coef-
ficient of variation of the duplicate capillary analyses performed in this study was 2.4 %, 
and that for the venous analyses was 2.6 %.
Statistical analysis
Data are presented as n (%) for categorical variables and as median (interquartile range) 
for continuous variables. Fisher’s exact test was used to compare group frequencies and 
the Mann–Whitney U test was used to compare group differences between medians. 
Simple logistic regression analysis was used to calculate Nagelkerke R2, and odds ratios 
(ORs) with 95 % confidence interval (CI). Variables tested for associations with diabe-
tes after GDM were non-European origin (yes/no), first-grade diabetes heredity (yes/no), 
age at delivery (years), glucose concentrations during OGTT (mmol/L), time interval to 
follow-up (years), BMI at follow-up (kg/m2), and parity, which was best expressed as up 
to three deliveries at follow-up versus more than three (≤3/>3). Diagnosis in early gesta-
tion (yes/no) and insulin treatment during pregnancy (yes/no) were also analyzed, but 
Study groups GNGT GDM
Included at 1- to 2-year follow-up 166 470
    Diabetes at 1-2 years 0 32
    Not reachable/moved 5 7
Invited to 5-year follow-up 161 431
    Diabetes after 1-2 years 0 13
    Declined 22 48
    Dropped out 12 29
    No results at 1-2 years 4 21
Included at 5-year follow-up 131 362
    Normal glucose tolerance 99 (76) 187 (52)
    Impaired fasting glucose 28 (21) 75 (21)
    Impaired glucose tolerance 4 (3) 72 (20)
    Diabetes 0 28 (8)
Fig. 1 Flow chart of the study population and diagnoses at 5-year follow-up. Number of participants and n 
(%) for diagnosis at 5-year follow-up are given. GNGT gestational normal glucose tolerance, GDM gestational 
diabetes mellitus
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they were not included in the final multiple model since these variables were deemed 
less stable depending on the screening strategy and the judgement by the physician.
Multivariable logistic regression analysis was done with either backward elimination 
of non-significant factors or forward adding of significant factors. Probability of diabetes 
(%) in the prediction model was calculated from the function: F(t) = et/(1 + et), where 
t is represented by the equation from the final multivariable regression (Hosmer and 
Lemeshow 2005). The performance of the prediction model was assessed in receiver-
operating characteristic (ROC) curves with calculations of area under the curve (AUC). 
Threshold for discrimination was calculated with the Youden index (Hajian-Tilaki 2013).
IBM SPSS Statistics 22 for Windows (IBM Corporation, Armonk, NY) was used 
for analysis. Two-sided P values of less than 0.05 were considered to be statistically 
significant.
Results
Altogether, 131 women with GNGT and 362 women with GDM had an OGTT 5 years 
postpartum (Fig. 1). Frequencies of overweight (BMI ≥ 25 kg/m2) in these groups were 
42 and 44  %, respectively, at the 1- to 2-year follow-up (P =  0.50), and 47  % in both 
groups at the 5-year follow-up. None of the women with GNGT were diagnosed with 
diabetes at the 1- to 2-year follow-up or later, whereas in addition to the 45 women 
already diagnosed with diabetes, 28 other women with previous GDM were diagnosed 
with diabetes at the 5-year appointment. Of the 72 women with IGT 5 years after GDM, 
32 (44 %) also had impaired fasting glucose (IFG).
Of the 362 women with previous GDM, 341 also had results from the 1- to 2-year fol-
low-up. Adding the 45 women already diagnosed with diabetes at 1- to 2-years or later, 
altogether 72/386 (19 %) of the women had a diabetes diagnosis 5 years after GDM. In 
women with IFG or IGT at the 1- to 2-year OGTT, 18/117 (15 %) had diabetes at the 
5-year OGTT. The corresponding figure in women with NGT at the 1- to 2-year OGTT 
was 9/224 (4 %). Using NGT as a reference, IFG or IGT at 1- to 2-year follow-up was 
associated with an increased risk of diabetes up to 5 years postpartum (OR 5.1, 95 % CI 
2.5–10.4, P < 10−5).
Comparing the 341 women who attended both the 1- to 2-year follow-up and the 
5-year follow-up with the 84 women (without a previous diabetes diagnosis) who were 
lost to 5-year follow-up, there were no significant differences in clinical characteristics 
such as ethnic origin, first-grade diabetes heredity, age at delivery, 2-h glucose level dur-
ing pregnancy, BMI or glucose levels during the OGTT at the 1- to 2-year follow-up.
In Table 1, clinical data from pregnancy and follow-up are given in relation to glucose 
category at the 5-year OGTT for women with previous GDM. Using NGT as a refer-
ence, women with diabetes were characterized by an increased frequency of non-Euro-
pean origin, higher 2-h glucose level during pregnancy, higher BMI at both follow-up 
visits, and higher fasting and 2-h glucose levels during the OGTT 1–2 years postpartum. 
Similarly, women with IFG/IGT had higher BMI than women with NGT. Snuff was used 
in less than 1 % of the women during pregnancy and follow-up, whereas 5 % smoked 
during pregnancy (as compared to 9–10 % during follow-up). There were no significant 
differences in the frequencies of tobacco use during pregnancy or follow-up between 
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women with GNGT and women with GDM; nor were there any differences in the fre-
quencies of smoking related to glucose tolerance at 5-year follow-up.
To investigate which variables were associated with development of diabetes up to 
5  years after GDM, women with NGT at 1- to 2-year follow-up and 5-year follow-up 
were used as reference (Table 2A). Of the variables tested for an association with diabe-
tes in the multivariable analysis, ethnic origin, 2-h glucose concentrations during preg-
nancy, and BMI at 1- to 2-year follow-up remained after backward elimination, while age 
at delivery and first-grade diabetes heredity were not significant in this study. Change 
in BMI from 1- to 2-year follow-up to 5-year follow-up was not significantly associated 
with diabetes in multivariable analysis when related to BMI at the respective follow-up. 
One woman with a weight loss of 43 % after pregnancy due to bariatric surgery and NGT 
at 5-year follow-up was excluded in later analyses.
Variables remaining after backward elimination in the multivariable regres-
sion analysis were used when constructing a model for diabetes prediction after 
GDM, including results from 200 women (67 diabetes, 133 NGT). Accordingly, 
ethnic origin (0 coding for European, and 1 coding for non-European, “E”), 2-h 
Table 1 Descriptive data from  pregnancy and  follow-up in  relation to  glucose category 
5 years after GDM
Data given are n (%) or median (interquartile range)
Differences were tested with Fisher’s exact test (categorical variables) or the Mann–Whitney U test (continuous variables)
GDM gestational diabetes mellitus, NGT normal glucose tolerance, IFG impaired fasting glucose, IGT impaired glucose 
tolerance, PG plasma glucose, FPG fasting plasma glucose
* All comparisons were performed against NGT





23 (13) 10 (15) 0.84 12 (18) 0.42 13 (48) <0.001
First-grade diabe-
tes heredity
47 (28) 24 (36) 0.27 28 (44) 0.027 16 (62) 0.001
Age at delivery 
(years)
32.1 (29.1–36.0) 32.3 (28.8–35.9) 0.99 34.6 (32.2–36.8) 0.002 35.4 (28.8–38.2) 0.060
Pregnancy
2-h PG (mmol/L) 9.3 (8.9–9.9) 9.3 (8.9–10.3) 0.43 9.5 (9.1–10.3) 0.083 10.1 (9.6–10.8) <0.001
Diagnosis in early 
gestation
8 (5.0) 5 (7.9) 0.53 7 (12) 0.13 6 (23) 0.006
Insulin treatment 12 (6.5) 7 (9.3) 0.44 8 (11) 0.20 6 (21) 0.018
1–2 years after pregnancy
Interval to follow-
up (years)
1.3 (1.0–1.7) 1.2 (1.0–1.5) 0.15 1.4 (1.2–1.6) 0.12 1.4 (1.1–1.7) 0.68
Deliveries >3 7 (4.0) 6 (8.5) 0.20 5 (7.2) 0.33 3 (10.7) 0.14
BMI (kg/m2) 23.0 (21.2–26.0) 24.1 (21.6–27.5) 0.010 24.4 (22.2–27.1) 0.011 27.0 (25.1–31) <10−6
FPG (mmol/L) 5.2 (4.9–5.6) 5.6 (5.2–6.0) <10−4 5.3 (5.0–5.8) 0.12 5.7 (5.2–6.3) <0.001
2-h PG (mmol/L) 5.8 (5.0–6.9) 6.4 (5.5–7.0) 0.043 7.4 (6.1–8.3) <10−8 7.2 (6.9–8.5) <10−6
5 years after pregnancy
Interval to follow-
up (years)
5.1 (5.0–5.2) 5.1 (5.0–5.3) 0.95 5.1 (5.0–5.3) 0.39 5.2 (5.0–5.5) 0.28
Deliveries >3 13 (7.0) 9 (12.0) 0.22 10 (13.9) 0.09 5 (18) 0.066
BMI (kg/m2) 23.4 (21.3–26.8) 25.0 (22.7–27.9) 0.005 25.8 (23.1–27.9) 0.001 28.0 (26.8–34.6) <10−7
FPG (mmol/L) 5.5 (5.3–5.8) 6.3 (6.2–6.5) <10−35 6.0 (5.6–6.4) <10−10 7.1 (6.8–7.2) <10−15
2-h PG (mmol/L) 7.4 (6.6–8.0) 7.7 (7.3–8.2) 0.003 9.7 (9.2–10.3) <10−34 12.2 (9.5–12.7) <10−13
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glucose concentration during pregnancy (“GP”), and BMI from the 1- to 2-year follow-
up were used to generate model A for prognostication of diabetes risk (%) with NGT at 
1–2  years and 5-years as reference: (Exp(1.919 ∗ E+ 0.703 ∗GP+ 0.274 ∗ BMI−15.5)) 
/(1+ Exp(1.919 ∗ E+ 0.703 ∗GP+ 0.274 ∗ BMI−15.5)) ∗ 100 . In this population, 
model A correctly prognosticated 86 % of the women with diabetes after GDM, with an 
AUC of 0.91 (95 % CI 0.86–0.95). A calculated optimal cutoff for diabetes risk of 36.4 % 
yielded a sensitivity of 82.1 %, a specificity of 88.0 %, a positive predictive value of 77.5 %, 
and a negative predictive value of 90.7 %.
With the idea of using analyzed follow-up data with the purpose of individual coun-
seling of women after pregnancy with GDM, we designed a function sheet with a line 
diagram relating possible weight to prognosticated risk of diabetes from model A. An 
individual example is shown in Fig. 2.
To investigate determinants of diabetes or NGT 5 years after GDM in women classi-
fied as IFG or IGT at 1- to 2-year follow-up, regression analyses were performed, add-
ing significant variables in a forward strategy—as the quantity of women in this analysis 
was limited (Table 2B). Based on these findings, a prognostication model B was devel-
oped, resulting in 88  % correct classifications in the 64 women included (28 diabetes, 
36 NGT), with an AUC of 0.93 (95 % CI 0.86‒0.99). An optimal cutoff of 54.9 % gave a 
sensitivity of 82.1 %, a specificity of 97.2 %, a positive predictive value of 95.8 %, and a 
negative predictive value of 87.5 %. The prognostication of diabetes risk (%) with NGT 
as reference was calculated as: (Exp(0.215 ∗ AD+ 2.156 ∗GP+ 0.271 ∗ BMI−35.783) 
/(1+ Exp(0.215 ∗ AD+ 2.156 ∗GP+ 0.271 ∗ BMI−35.783)) ∗ 100 , with “AD” repre-
senting age at delivery and “GP” representing 2-h plasma glucose concentration during 
























Your weight against predicted risk of diabetes 
Circle your current weight and draw an arrow to your desired weight. 
Put a cross each month to log  your progress towards your goal. 
Fig. 2 Line diagram representing an individually predicted risk of diabetes 5 years after GDM versus weight. 
This example illustrates the risk for a European woman with a height of 1.64 m, a 2-h OGTT capillary plasma 
glucose concentration of 10.2 mmol/L in pregnancy, and a current weight of 90 kg—resulting in a predicted 
70 % risk of diabetes with a constant weight and declining to a 18 % risk with a weight loss of 23 kg
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Discussion
To the best of our knowledge, this is the first study to use long-term follow-up data after 
GDM in prediction models to aid in individual counseling. The prediction models per-
formed well with 86 % correct classifications in model A and an AUC of 91 %. Prognos-
tication for women with IFG or IGT 1–2 years after GDM in model B gave even better 
results, although these were based on fewer women. Excluding women previously diag-
nosed with diabetes, an additional 8  % of the women with previous GDM were diag-
nosed with diabetes at the 5-year follow-up, whereas none of the women with normal 
glucose tolerance during pregnancy were diagnosed with diabetes during the follow-up 
period. These findings suggest that the 2-h glucose threshold value of the WHO 1999 
diagnostic criteria for GDM could be regarded as a watershed for diabetes development 
after GDM. However, the groups were not completely comparable, with high-risk ethnic 
origin in particular being overrepresented in women with GDM (Anderberg et al. 2011).
The variables included in the proposed models might well be accompanied or replaced 
by other risk factors in repeated studies and other populations. Age, first-grade diabetes 
heredity, and parity >3 were less stable predictors, which might be attributed to signifi-
cant confounding with a non-European background in this population. Non-European 
origin was more frequently represented among women diagnosed with diabetes 5 years 
after GDM, as also previously described and analyzed from the 1- to 2-year follow-up 
(Ignell et al. 2013). In contrast, an Austrian group assessing a cluster of risk factors for 
diabetes manifestation up to 10 years after GDM did not observe any effect of non-Euro-
pean origin (Göbl et al. 2011). This discrepancy may be explained by differences in the 
composition of the non-European groups in the two studies. When using broader eth-
nic classifications, caution is warranted, as considerable differences can exist even within 
apparently well-defined populations (WHO Expert Consultation 2004).
When analyzing diabetes prediction up to 5 years after GDM, data from women with 
NGT at 1- to 2-year follow-up and 5-year follow-up were used as reference, to get a 
clear-cut discrimination (prediction model A). Furthermore, we found it worthwhile to 
investigate determinants of diabetes after being diagnosed with IFG or IGT at the 1- to 
2-year follow-up, using NGT at 5 years as reference (prediction model B). However, the 
diagnosis of these intermediate glucose categories is known to be more prone to error 
than the diagnosis of diabetes, and there is an ongoing debate on how well these catego-
ries predict diabetes (Yudkin and Montori 2014). For this reason, and since model A was 
based on a larger number of women, we focused on model A—which was described in 
greater detail and used in the prediction model line diagram (Fig. 2). The cutoff points 
identified concerning prediction of diabetes risk, resulting in high predictive values for 
both models, may not be good enough to be used by clinicians to refrain from further 
follow-up. For this purpose, completing the models with more sophisticated analyses 
might prove to be effective (Barden et al. 2013).
A limitation of the study was the rather low overall participation rate in the Mamma 
Study; less than 50 % of consenting women with previous GDM took part in the 1- to 
2-year follow-up (Anderberg et  al. 2011). Studies have repeatedly shown poor com-
pliance with recommended guidelines in clinical practice, and women fail to attend 
the postpartum visit, even in the research setting (Carson et  al. 2013). As previ-
ously reported, the only information available concerning non-participants at the first 
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follow-up was their age (Anderberg et  al. 2011). This is a clear limitation since differ-
ences in known risk factors for diabetes, such as BMI, family history of diabetes and 
ethnic background between participants and non-participants will have an impact on 
the prevalence of diabetes after GDM. Nevertheless, 85 % of eligible women from the 
first follow-up took part in the 5-year follow-up, and it is a strength that their previously 
recorded data from the 1- to 2-year follow-up was not significantly different from the 
data from those who declined participation or dropped out. The participation rate at 
the first-follow-up might have been improved if follow-up had been performed at the 
regular maternal care visit 3 months after delivery, which would also have been valuable 
since early conversion to type-2 diabetes is not uncommon (Kim et al. 2002; Kwak et al. 
2013; Capula et al. 2014). Unfortunately, we did not have access to weight in early or late 
gestation, fasting glucose concentrations at diagnosis in pregnancy, or HbA1c levels for 
the entire population—factors that could have improved the prediction models further 
(Capula et al. 2014; Kwak et al. 2013; Ekelund et al. 2010). Although BMI shows a good 
correlation with percentage of body fat, there are variations according to ethnicity and 
age (WHO Expert Consultation 2004). Measurements of waist circumference might also 
have added new and valuable data, especially if combined with height, as reported by 
Gruson et al. (WHO Expert Consultation 2004; Gruson et al. 2010; Wang et al. 2014).
Different models for prediction of type-2 diabetes in women with GDM have been 
presented recently (Cormier et al. 2015; Capula et al. 2014; Barden et al. 2013). Cormier 
et al. evaluated the predictive value in ROC curves of a genetic risk score with 36 single-
nucleotide polymorphisms (Cormier et al. 2015). Combined with BMI and age, an AUC 
of 0.67 for the prediction of diabetes versus NGT was reported, based on 214 women 
with a mean follow-up time of 3.5 years after GDM. Including information on glucose 
concentration from pregnancy in prediction models appears to be of major impor-
tance. Capula et al. reported an AUC of 0.90 for fasting plasma glucose concentration 
at GDM screening for the prediction of diabetes 6–12 weeks postpartum (Capula et al. 
2014). Furthermore, Barden et al. reported that a fasting plasma glucose concentration 
of >5.5 mmol/L at diagnosis during pregnancy was almost as effective as a “high-risk” 
cluster of cardiometabolic risk factors to predict diabetes 10 years after GDM (Barden 
et al. 2013). Similarly, in a previous study we found that a fasting blood glucose level of 
≥5.2 mmol/L was associated with a fourfold to sixfold increased risk of diabetes 5 years 
after GDM (Ekelund et al. 2010).
The method of motivational interviewing has been shown to be useful when coun-
seling to enhance weight loss (Armstrong et  al. 2011). The concept of using a predic-
tion model in a function-sheet line diagram to illustrate an individualized risk in relation 
to a modifiable risk factor might prove to be a useful tool for visual information and 
interaction when motivating women to a healthy lifestyle and to increase compliance to 
follow-up.
Conclusion
The diagnostic 2-h OGTT glucose concentration during pregnancy, non-European ori-
gin, and BMI at the first postpartum follow-up was found to be associated with diabetes 
development up to 5 years after GDM. The results highlight the importance of BMI as 
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a potentially modifiable risk factor for diabetes. Our proposed prediction models per-
formed well with large proportions of correct classifications, and should encourage fur-
ther validation in other populations in future studies.
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